Want to Beat the Bear Market? Try These 2 Stocks

The bear market has sent plenty of great companies into the doldrums. Most of us know that just by looking at our portfolios. And that's OK. We're in this for the long term. Once economic pressures ease, our favorite companies have a great chance of rebounding -- and gaining over time.

Meanwhile, it's always a good idea to pick up a stock that has resisted the general negative market move. Two drugmakers have done just that. Vertex Pharmaceuticals (NASDAQ: VRTX) and AbbVie (NYSE: ABBV) are both gaining so far this year -- even as the S&P 500 declines. They've climbed 32% and 12%, respectively. The S&P 500 has lost 19%. It's impossible to predict whether this trend will continue. But we can say these two companies have what it takes to keep going strong. Let's find out more.

Vertex is already bringing in billions of dollars in revenue and profit from its cystic fibrosis (CF) business. The company's top drug, Trikafta, has the ability to treat 90% of CF patients. But it hasn't reached that full population yet. That means there's room for even more growth for this blockbuster.

Continue reading

Source Fool.com